{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:57:44Z","timestamp":1787738264559,"version":"build-2784847793"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.seizure.2022.11.008","type":"journal-article","created":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T18:01:11Z","timestamp":1668362471000},"page":"137-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Role of SERPINI1 pathogenic variants in familial encephalopathy with neuroserpin inclusion bodies: A case report and literature review"],"prefix":"10.1016","volume":"103","author":[{"given":"Xiaoyue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiong","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S2","key":"10.1016\/j.seizure.2022.11.008_bib0001","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1684\/epd.2016.0847","article-title":"Progressive myoclonus epilepsy associated with neuroserpin inclusion bodies (neuroserpinosis)","volume":"18","author":"Roussel","year":"2016","journal-title":"Epileptic Disord"},{"issue":"1","key":"10.1016\/j.seizure.2022.11.008_bib0002","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1212\/01.wnl.0000316306.08751.28","article-title":"Neuroserpin mutation causes electrical status epilepticus of slow-wave sleep","volume":"71","author":"Coutelier","year":"2008","journal-title":"Neurology"},{"issue":"19\u201320","key":"10.1016\/j.seizure.2022.11.008_bib0003","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1007\/s00018-021-03907-6","article-title":"Neuroserpin: structure, function, physiology and pathology","volume":"78","author":"D'Acunto","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.seizure.2022.11.008_bib0004","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.mcn.2005.09.005","article-title":"The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo","volume":"30","author":"Lebeurrier","year":"2005","journal-title":"Mol Cell Neurosci"},{"issue":"12","key":"10.1016\/j.seizure.2022.11.008_bib0005","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI0214308","article-title":"Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent","volume":"109","author":"Yepes","year":"2002","journal-title":"J Clin Invest"},{"issue":"9325","key":"10.1016\/j.seizure.2022.11.008_bib0006","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/S0140-6736(02)09293-0","article-title":"Association between conformational mutations in neuroserpin and onset and severity of dementia [published correction appears in Lancet 2002 Oct 5;360(9339):1102]","volume":"359","author":"Davis","year":"2002","journal-title":"Lancet"},{"issue":"27","key":"10.1016\/j.seizure.2022.11.008_bib0007","doi-asserted-by":"crossref","first-page":"18202","DOI":"10.1074\/jbc.M109.010744","article-title":"Neuroserpin polymers activate NF-kappaB by a calcium signaling pathway that is independent of the unfolded protein response","volume":"284","author":"Davies","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.seizure.2022.11.008_bib0008","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1212\/WNL.36.1.68","article-title":"Progressive dementia and epilepsy in a young adult: unusual intraneuronal inclusions","volume":"36","author":"Yerby","year":"1986","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.seizure.2022.11.008_bib0009","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jnen\/59.12.1070","article-title":"Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy","volume":"59","author":"Takao","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2022.11.008_bib0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1212\/01.wnl.0000265052.99144.b5","article-title":"Clinical and neuropathologic study of a French family with a mutation in the neuroserpin gene","volume":"69","author":"Gourfinkel-An","year":"2007","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.seizure.2022.11.008_bib0011","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1750-3639.2011.00481.x","article-title":"Encephalopathy with neuroserpin inclusion bodies presenting as progressive myoclonus epilepsy and associated with a novel mutation in the Proteinase Inhibitor 12 gene","volume":"21","author":"Hagen","year":"2011","journal-title":"Brain Pathol"},{"issue":"9","key":"10.1016\/j.seizure.2022.11.008_bib0012","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/ajmg.a.38317","article-title":"SERPINI1 pathogenic variants: an emerging cause of childhood-onset progressive myoclonic epilepsy","volume":"173","author":"Ranza","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.seizure.2022.11.008_bib0013","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jns.2017.11.029","article-title":"A Japanese family with mutation in the proteinase inhibitor 12 L47P gene: a case report","volume":"384","author":"Amano-Takeshige","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.seizure.2022.11.008_bib0014","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.seizure.2020.06.022","article-title":"Early-onset rapidly progressive myoclonic epilepsy associated with G392R likely pathogenic variant in SERPINI1","volume":"80","author":"Kara","year":"2020","journal-title":"Seizure"},{"issue":"7","key":"10.1016\/j.seizure.2022.11.008_bib0015","first-page":"649","article-title":"A Chinese pedigree of familial encephalopathy with neuroserpin inclusions bodies","volume":"54","author":"Shuai","year":"2021","journal-title":"Chin J Neurol"},{"issue":"6751","key":"10.1016\/j.seizure.2022.11.008_bib0016","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/43894","article-title":"Familial dementia caused by polymerization of mutant neuroserpin","volume":"401","author":"Davis","year":"1999","journal-title":"Nature"},{"issue":"Suppl 5","key":"10.1016\/j.seizure.2022.11.008_bib0017","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.0013-9580.2004.05002.x","article-title":"Diagnosis of infantile spasms, Lennox-Gastaut syndrome, and progressive myoclonic epilepsy","volume":"45","author":"Shields","year":"2004","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2022.11.008_bib0018","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1474-4422(05)70043-0","article-title":"Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects","volume":"4","author":"Shahwan","year":"2005","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.seizure.2022.11.008_bib0019","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00018-022-04185-6","article-title":"Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell-cell interactions in the pathophysiology of neurological disease","volume":"79","author":"Godinez","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.seizure.2022.11.008_bib0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40272-019-00378-y","article-title":"Drug treatment of progressive myoclonic epilepsy","volume":"22","author":"Holmes","year":"2020","journal-title":"Paediatr Drugs"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122002618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122002618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:02:20Z","timestamp":1761012140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131122002618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":20,"alternative-id":["S1059131122002618"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2022.11.008","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of SERPINI1 pathogenic variants in familial encephalopathy with neuroserpin inclusion bodies: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2022.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}